-
1
-
-
84861315357
-
Guidelines for the management of androgenetic alopecia
-
Tsuboi R, Itami S, Inui S, et al. Guidelines for the management of androgenetic alopecia. J Dermatol 2012;39(2):113-20
-
(2012)
J Dermatol
, vol.39
, Issue.2
, pp. 113-120
-
-
Tsuboi, R.1
Itami, S.2
Inui, S.3
-
2
-
-
0033811542
-
Androgenetic alopecia and microinflammation
-
Mahe'YF Michelet JF, Billoni N, et al. Androgenetic alopecia and microinflammation. Int J Dermatol 2000;39(8):576-84
-
(2000)
Int J Dermatol
, vol.39
, Issue.8
, pp. 576-584
-
-
Mahe'YF Michelet, J.F.1
Billoni, N.2
-
3
-
-
0345600190
-
Is androgenetic alopecia a photoaggravated dermatosis
-
Trueeb R. Is androgenetic alopecia a photoaggravated dermatosis? Dermatology 2003;207(4):343-8
-
(2003)
Dermatology
, vol.207
, Issue.4
, pp. 343-348
-
-
Trueeb, R.1
-
5
-
-
77958162673
-
Efficacy and safety of finasteride therapy for androgenetic alopecia: A systematic review
-
Mella JM, Perret MC, Manzotti M, et al. Efficacy and safety of finasteride therapy for androgenetic alopecia: A systematic review. Arch Dermatol 2010;146(10):1141-50
-
(2010)
Arch Dermatol
, vol.146
, Issue.10
, pp. 1141-1150
-
-
Mella, J.M.1
Perret, M.C.2
Manzotti, M.3
-
6
-
-
0037357915
-
Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss
-
Whiting DA, Olsen EA, Savin R, et al. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. Eur J Dermatol 2003;13(2):150-60
-
(2003)
Eur J Dermatol
, vol.13
, Issue.2
, pp. 150-160
-
-
Whiting, D.A.1
Olsen, E.A.2
Savin, R.3
-
7
-
-
0042634152
-
The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia
-
Tang L, Bernardo O, Bolduc C, et al. The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia. J Am Acad Dermatol 2003;49(2):229-33
-
(2003)
J Am Acad Dermatol
, vol.49
, Issue.2
, pp. 229-233
-
-
Tang, L.1
Bernardo, O.2
Bolduc, C.3
-
8
-
-
84919493544
-
Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: A serious concern or red herring
-
Singh MK, Avram M. Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: A serious concern or red herring? J Clin Aesthet Dermatol 2014;7(12):51-5
-
(2014)
J Clin Aesthet Dermatol
, vol.7
, Issue.12
, pp. 51-55
-
-
Singh, M.K.1
Avram, M.2
-
9
-
-
0032843781
-
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men
-
Overstreet JW, Fuh VL, Gould J, et al. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol 1999;162(4):1295-300
-
(1999)
J Urol
, vol.162
, Issue.4
, pp. 1295-1300
-
-
Overstreet, J.W.1
Fuh, V.L.2
Gould, J.3
-
10
-
-
84888420575
-
Finasteride use in the male infertility population: Effects on semen and hormone parameters
-
Samplaski MK, Lo K, Grober E, Jarvi K. Finasteride use in the male infertility population: effects on semen and hormone parameters. Fertil Steril 2013;100(6):1542-6
-
(2013)
Fertil Steril
, vol.100
, Issue.6
, pp. 1542-1546
-
-
Samplaski, M.K.1
Lo, K.2
Grober, E.3
Jarvi, K.4
-
11
-
-
79953315659
-
Finasteride induced gynecomastia: Case report and review of the literature
-
Ramot Y, Czarnowicki T, Zlotogorski A. Finasteride induced Gynecomastia: Case report and Review of the Literature. Int J Trichology 2009;1(1):27-9
-
(2009)
Int J Trichology
, vol.1
, Issue.1
, pp. 27-29
-
-
Ramot, Y.1
Czarnowicki, T.2
Zlotogorski, A.3
-
12
-
-
0037812658
-
The influence of finasteride on the development of prostate cancer
-
Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349(3):215-24
-
(2003)
N Engl J Med
, vol.349
, Issue.3
, pp. 215-224
-
-
Thompson, I.M.1
Goodman, P.J.2
Tangen, C.M.3
-
13
-
-
84931053296
-
Adverse event reporting in clinical trials of finasteride for androgenic alopecia: A meta-analysis
-
[Epub ahead of print]
-
Belknap SM, Aslam I, Kiguradze T, et al. Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis. JAMA Dermatol 2015. [Epub ahead of print]
-
(2015)
JAMA Dermatol
-
-
Belknap, S.M.1
Aslam, I.2
Kiguradze, T.3
-
14
-
-
84912059201
-
A novel finasteride 0.25% topical solution for androgenetic alopecia: Pharmacokinetics and effects on plasma androgen levels in healthy male volunteers
-
Caserini M, Radicioni M, Leuratti C, et al. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. Int J Clin Pharmacol Ther 2014;52(10):842-9
-
(2014)
Int J Clin Pharmacol Ther
, vol.52
, Issue.10
, pp. 842-849
-
-
Caserini, M.1
Radicioni, M.2
Leuratti, C.3
-
15
-
-
0032722225
-
Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment
-
Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol 1999;41(5Pt1):717-21
-
(1999)
J Am Acad Dermatol
, vol.41
, Issue.5
, pp. 717-721
-
-
Price, V.H.1
Menefee, E.2
Strauss, P.C.3
-
16
-
-
0036737739
-
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
-
Olsen EA, Dunlap F, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002;47(3):377-85
-
(2002)
J Am Acad Dermatol
, vol.47
, Issue.3
, pp. 377-385
-
-
Olsen, E.A.1
Dunlap, F.2
Funicella, T.3
-
17
-
-
35148886772
-
A multicenter, randomized, placebocontrolled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men
-
Olsen EA, Whiting D, Bergfeld W, et al. A multicenter, randomized, placebocontrolled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2007;57(5):767-74
-
(2007)
J Am Acad Dermatol
, vol.57
, Issue.5
, pp. 767-774
-
-
Olsen, E.A.1
Whiting, D.2
Bergfeld, W.3
-
18
-
-
84920902013
-
Clinical utility and validity of minoxidil response testing in androgenetic alopecia
-
Goren A, Shapiro J, Roberts J, et al. Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatol Ther 2015;28(1):13-16
-
(2015)
Dermatol Ther
, vol.28
, Issue.1
, pp. 13-16
-
-
Goren, A.1
Shapiro, J.2
Roberts, J.3
-
19
-
-
0031030541
-
Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growthstimulating effect
-
Michelet JF, Commo S, Billoni N, et al. Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growthstimulating effect. J Invest Dermatol 1997;108:205-9
-
(1997)
J Invest Dermatol
, vol.108
, pp. 205-209
-
-
Michelet, J.F.1
Commo, S.2
Billoni, N.3
-
20
-
-
0141596174
-
Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal
-
Tosti A, Iorizzo M, Vincenzi C. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal. Arch Dermatol 2003;139(9):1221-2
-
(2003)
Arch Dermatol
, vol.139
, Issue.9
, pp. 1221-1222
-
-
Tosti, A.1
Iorizzo, M.2
Vincenzi, C.3
-
21
-
-
0036160607
-
Allergic contact dermatitis to topical minoxidil solution: Etiology and treatment
-
Friedman ES, Friedman PS, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol 2002;46(2):309-12
-
(2002)
J Am Acad Dermatol
, vol.46
, Issue.2
, pp. 309-312
-
-
Friedman, E.S.1
Friedman, P.S.2
Cohen, D.E.3
Washenik, K.4
-
22
-
-
51349156637
-
Medical treatments for male and female pattern hair loss
-
Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol 2008;59(4):547-66
-
(2008)
J Am Acad Dermatol
, vol.59
, Issue.4
, pp. 547-566
-
-
Rogers, N.E.1
Avram, M.R.2
-
23
-
-
33750830522
-
The importance of dual 5alphareductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride
-
Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alphareductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol 2006;55(6):1014-23
-
(2006)
J Am Acad Dermatol
, vol.55
, Issue.6
, pp. 1014-1023
-
-
Olsen, E.A.1
Hordinsky, M.2
Whiting, D.3
-
24
-
-
77955292679
-
Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebocontrolled, phase III study
-
Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebocontrolled, phase III study. J Am Acad Dermatol 2010;63(2):252-8
-
(2010)
J Am Acad Dermatol
, vol.63
, Issue.2
, pp. 252-258
-
-
Eun, H.C.1
Kwon, O.S.2
Yeon, J.H.3
-
25
-
-
84894075744
-
A randomized, active-and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia
-
Gubelin Harcha W, Barboza Martnez J, Tsai TF, et al. A randomized, active-and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol 2014;70(3):489-98
-
(2014)
J Am Acad Dermatol
, vol.70
, Issue.3
, pp. 489-498
-
-
Gubelin Harcha, W.1
Barboza Martnez, J.2
Tsai, T.F.3
-
26
-
-
84873408493
-
Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia
-
Boyapati A, Sinclair R. Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia. Australas J Dermatol 2013;54(1):49-51
-
(2013)
Australas J Dermatol
, vol.54
, Issue.1
, pp. 49-51
-
-
Boyapati, A.1
Sinclair, R.2
-
27
-
-
84890319168
-
The efficacy and safety of 5a-reductase inhibitors in androgenetic alopecia: A network metaanalysis and benefit-risk assessment of finasteride and dutasteride
-
Gupta AK, Charrette A. The efficacy and safety of 5a-reductase inhibitors in androgenetic alopecia: A network metaanalysis and benefit-risk assessment of finasteride and dutasteride. J Dermatolog Treat 2014;25(2):156-61
-
(2014)
J Dermatolog Treat
, vol.25
, Issue.2
, pp. 156-161
-
-
Gupta, A.K.1
Charrette, A.2
-
28
-
-
84869180482
-
Hair transplantation update: Procedural techniques, innovations and applications
-
Bunagan MJK, Banka N, Shapiro J. Hair transplantation update: procedural techniques, innovations and applications. Dermatol Clin 2013;31:141-53
-
(2013)
Dermatol Clin
, vol.31
, pp. 141-153
-
-
Bunagan, M.J.K.1
Banka, N.2
Shapiro, J.3
-
29
-
-
33750238651
-
The role of platelet plasma growth factors in male pattern baldness surgery
-
Uebel CO, da Silva JB, Cantarelli D, Martins P. The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg 2006;118(6):1458-66
-
(2006)
Plast Reconstr Surg
, vol.118
, Issue.6
, pp. 1458-1466
-
-
Uebel, C.O.1
Da Silva, J.B.2
Cantarelli, D.3
Martins, P.4
-
30
-
-
84929516162
-
Promising alternative clinical uses of prostaglandin F2a analogs: Beyond the eyelashes
-
Choi YM, Diehl JM, Levins PC. Promising alternative clinical uses of prostaglandin F2a analogs: Beyond the eyelashes. J Am Acad Dermatol 2015;4:712-16
-
(2015)
J Am Acad Dermatol
, vol.4
, pp. 712-716
-
-
Choi, Y.M.1
Diehl, J.M.2
Levins, P.C.3
-
31
-
-
84859849330
-
A randomized double-blind placebocontrolled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
-
Blume-Peytavi U, Lonnfors S, Hillmann K, Garcia Bartels N. A randomized double-blind placebocontrolled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. J Am Acad Dermatol 2012;66(5):794-800
-
(2012)
J Am Acad Dermatol
, vol.66
, Issue.5
, pp. 794-800
-
-
Blume-Peytavi, U.1
Lonnfors, S.2
Hillmann, K.3
Garcia Bartels, N.4
-
32
-
-
84873437891
-
The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias
-
Khidhir KG, Woodward DF, Farjo NP, et al. The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias. FASEB J 2013;27(2):557-67
-
(2013)
FASEB J
, vol.27
, Issue.2
, pp. 557-567
-
-
Khidhir, K.G.1
Woodward, D.F.2
Farjo, N.P.3
-
34
-
-
84881381686
-
Low-level light therapy for androgenetic alopecia: A 24-week, randomized, doubleblind, sham device-controlled multicenter trial
-
Kim H, Choi JW, Kim JY, et al. Low-level light therapy for androgenetic alopecia: A 24-week, randomized, doubleblind, sham device-controlled multicenter trial. Dermatol Surg 2013;39(8):1177-83
-
(2013)
Dermatol Surg
, vol.39
, Issue.8
, pp. 1177-1183
-
-
Kim, H.1
Choi, J.W.2
Kim, J.Y.3
-
35
-
-
84899701624
-
Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: A multicenter, randomized, sham devicecontrolled, double-blind study
-
Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: A multicenter, randomized, sham devicecontrolled, double-blind study. Am J Clin Dermatol 2014;15(2):115-27
-
(2014)
Am J Clin Dermatol
, vol.15
, Issue.2
, pp. 115-127
-
-
Jimenez, J.J.1
Wikramanayake, T.C.2
Bergfeld, W.3
-
36
-
-
67849099583
-
The use of low-level light for hair growth: Part i
-
Avram MR, Rogers NE. The use of low-level light for hair growth: part I. J Cosmet Laser Ther 2009;11(2):110-17
-
(2009)
J Cosmet Laser Ther
, vol.11
, Issue.2
, pp. 110-117
-
-
Avram, M.R.1
Rogers, N.E.2
-
37
-
-
84894270456
-
Low-level laser (light) therapy for treatment of hair loss
-
Avci P, Gupta GK, Clark J, et al. Low-level laser (light) therapy for treatment of hair loss. Laser Surg Med 2014;46(2):144-51
-
(2014)
Laser Surg Med
, vol.46
, Issue.2
, pp. 144-151
-
-
Avci, P.1
Gupta, G.K.2
Clark, J.3
-
38
-
-
84923262011
-
Platelet-rich plasma in androgenic alopecia: Myth or an effective tool
-
Khatu SS, More YE, Gokhale NR, et al. Platelet-rich plasma in androgenic alopecia: myth or an effective tool. J Cutan Aesthet Surg 2014;7(2):107-10
-
(2014)
J Cutan Aesthet Surg
, vol.7
, Issue.2
, pp. 107-110
-
-
Khatu, S.S.1
More, Y.E.2
Gokhale, N.R.3
-
39
-
-
84942193466
-
Autologous PRP injections in androgenic alopecia
-
Amgar G, Bouhanna P. Autologous PRP injections in androgenic alopecia. Prime 2015;5(2):24-34
-
(2015)
Prime
, vol.5
, Issue.2
, pp. 24-34
-
-
Amgar, G.1
Bouhanna, P.2
-
40
-
-
84868207008
-
Evidence-based treatments for female pattern hair loss: A summary of a Cochrane systematic review
-
Van Zuuren EJ, Fedorowicz Z, Carter B. Evidence-based treatments for female pattern hair loss: A summary of a Cochrane systematic review. Br J Dermatol 2012;167(5):995-1010
-
(2012)
Br J Dermatol
, vol.167
, Issue.5
, pp. 995-1010
-
-
Van Zuuren, E.J.1
Fedorowicz, Z.2
Carter, B.3
-
41
-
-
84883429643
-
Female pattern alopecia: Current perspectives
-
Levy LL, Emer JJ. Female pattern alopecia: current perspectives. Int J Women Health 2013;29(5):541-56
-
(2013)
Int J Women Health
, vol.29
, Issue.5
, pp. 541-556
-
-
Levy, L.L.1
Emer, J.J.2
-
42
-
-
81155150327
-
A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women
-
Blume-Peytavi U, Hillmann K, Dietz E, et al. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol 2011;65(6):1126-34
-
(2011)
J Am Acad Dermatol
, vol.65
, Issue.6
, pp. 1126-1134
-
-
Blume-Peytavi, U.1
Hillmann, K.2
Dietz, E.3
-
43
-
-
33845990900
-
Antiandrogen therapy for androgenetic alopecia
-
Yip L, Sinclair R. Antiandrogen therapy for androgenetic alopecia. Expert Rev Dermatol 2006;1(2):261-9
-
(2006)
Expert Rev Dermatol
, vol.1
, Issue.2
, pp. 261-269
-
-
Yip, L.1
Sinclair, R.2
-
44
-
-
0036067176
-
Effects of minoxidil 2% vs cyproterone acetate treatment on female androgenetic alopecia: A controlled, 12-month randomized trial
-
Vexiau P, Chaspoux C, Boudou P, et al. Effects of minoxidil 2% vs cyproterone acetate treatment on female androgenetic alopecia: A controlled, 12-month randomized trial. Br J Dermatol 2002;146(6):992-9
-
(2002)
Br J Dermatol
, vol.146
, Issue.6
, pp. 992-999
-
-
Vexiau, P.1
Chaspoux, C.2
Boudou, P.3
-
45
-
-
0037227510
-
Treatment of hyperandrogenic alopecia in women
-
Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil Steril 2003;79(1):91-5
-
(2003)
Fertil Steril
, vol.79
, Issue.1
, pp. 91-95
-
-
Carmina, E.1
Lobo, R.A.2
-
46
-
-
79955631133
-
Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss
-
Paradisi R, Porcu E, Fabbri R, et al. Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss. Ann Pharmacother 2001;45(4):469-75
-
(2001)
Ann Pharmacother
, vol.45
, Issue.4
, pp. 469-475
-
-
Paradisi, R.1
Porcu, E.2
Fabbri, R.3
-
47
-
-
0033752238
-
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia
-
Price VH, Roberts Jl, Hordinsky M, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000;43(5Pt1):768-76
-
(2000)
J Am Acad Dermatol
, vol.43
, Issue.5
, pp. 768-776
-
-
Price, V.H.1
Roberts, J.L.2
Hordinsky, M.3
-
48
-
-
33645110044
-
Finasteride treatment in female pattern hair loss
-
Iorizzo M, Vincenzi C, Voudouris S, et al. Finasteride treatment in female pattern hair loss. Arch Dermatol 2006;142(3):298-302
-
(2006)
Arch Dermatol
, vol.142
, Issue.3
, pp. 298-302
-
-
Iorizzo, M.1
Vincenzi, C.2
Voudouris, S.3
-
49
-
-
27144458443
-
Effective treatment of female androgenic alopecia with dutasteride
-
Olszewska M, Rudnika L. Effective treatment of female androgenic alopecia with dutasteride. J Drugs Dermatol 2005;4(5):637-40
-
(2005)
J Drugs Dermatol
, vol.4
, Issue.5
, pp. 637-640
-
-
Olszewska, M.1
Rudnika, L.2
-
50
-
-
84973412366
-
The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia
-
Boersma IH, Oranje AP, Grimalt R, et al. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. Indian J Dermatol Venereol Leprol 2014;80(6):521-5
-
(2014)
Indian J Dermatol Venereol Leprol
, vol.80
, Issue.6
, pp. 521-525
-
-
Boersma, I.H.1
Oranje, A.P.2
Grimalt, R.3
-
51
-
-
77954879970
-
Androgenetic alopecia in the paediatric population: A retrospective review of 57 patients
-
Gonzalez ME, Cantatore-Francis J, Orlow SJ. Androgenetic alopecia in the paediatric population: A retrospective review of 57 patients. Br J Dermatol 2010;163(2):378-85
-
(2010)
Br J Dermatol
, vol.163
, Issue.2
, pp. 378-385
-
-
Gonzalez, M.E.1
Cantatore-Francis, J.2
Orlow, S.J.3
-
52
-
-
84860346016
-
British Association of Dermatologists' guidelines for the management of alopecia areata 2012
-
Messenger AG, McKillop J, Farrant P, et al. British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol 2012;166(5):916-26
-
(2012)
Br J Dermatol
, vol.166
, Issue.5
, pp. 916-926
-
-
Messenger, A.G.1
McKillop, J.2
Farrant, P.3
-
53
-
-
84861371950
-
Alopecia areata: A new treatment plan
-
Alsantali A. Alopecia areata: A new treatment plan. Clin Cosmet Investig Dermatol 2011;4:107-15
-
(2011)
Clin Cosmet Investig Dermatol
, vol.4
, pp. 107-115
-
-
Alsantali, A.1
-
54
-
-
0037710129
-
Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis
-
Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 2003;49(1):96-8
-
(2003)
J Am Acad Dermatol
, vol.49
, Issue.1
, pp. 96-98
-
-
Tosti, A.1
Piraccini, B.M.2
Pazzaglia, M.3
Vincenzi, C.4
-
55
-
-
33750300542
-
Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: A randomized, double-blind placebo-controlled trial
-
Tosti A, Iorizzo M, Botta GL, Milani M. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: A randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol 2006;20(10):1243-7
-
(2006)
J Eur Acad Dermatol Venereol
, vol.20
, Issue.10
, pp. 1243-1247
-
-
Tosti, A.1
Iorizzo, M.2
Botta, G.L.3
Milani, M.4
-
56
-
-
34948821188
-
Pulse corticosteroid therapy for alopecia areata: Study of 139 patients
-
Nakajima T, Inui S, Itami S. Pulse corticosteroid therapy for alopecia areata: study of 139 patients. Dermatology 2007;215(4):320-4
-
(2007)
Dermatology
, vol.215
, Issue.4
, pp. 320-324
-
-
Nakajima, T.1
Inui, S.2
Itami, S.3
-
57
-
-
42049107760
-
Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy
-
Hubiche T, Leaute-Labreze C, Taeb A, Boralevi F. Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy. Br J Dermatol 2008;158(5):1136-7
-
(2008)
Br J Dermatol
, vol.158
, Issue.5
, pp. 1136-1137
-
-
Hubiche, T.1
Leaute-Labreze, C.2
Täeb, A.3
Boralevi, F.4
-
58
-
-
0031710804
-
Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients
-
Friedli A, Labarthe MP, Engelhardt E, et al. Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients. J Am Acad Dermatol 1998;39(4Pt 1):597-602
-
(1998)
J Am Acad Dermatol
, vol.39
, Issue.4
, pp. 597-602
-
-
Friedli, A.1
Labarthe, M.P.2
Engelhardt, E.3
-
59
-
-
0030045892
-
Pulsed administration of corticosteroids in the treatment of alopecia areata
-
Sharma VK. Pulsed administration of corticosteroids in the treatment of alopecia areata. Int J Dermatol 1996;35(2):133-6
-
(1996)
Int J Dermatol
, vol.35
, Issue.2
, pp. 133-136
-
-
Sharma, V.K.1
-
60
-
-
0032881006
-
Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata
-
Sharma VK, Gupta S. Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata. J Dermatol 1999;26(9):562-5
-
(1999)
J Dermatol
, vol.26
, Issue.9
, pp. 562-565
-
-
Sharma, V.K.1
Gupta, S.2
-
62
-
-
73649139228
-
Alopecia areata update: Part II,treatment
-
Alkhalifah A, Alsantali A, Wang E, et al. Alopecia areata update: part II. Treatment. J Am Acad Dermatol 2010;62(2):191-202
-
(2010)
J Am Acad Dermatol
, vol.62
, Issue.2
, pp. 191-202
-
-
Alkhalifah, A.1
Alsantali, A.2
Wang, E.3
-
63
-
-
0031742416
-
Efficacy of topical sensitizers in the treatment of alopecia areata
-
Rokhsar CK, Shupack JL, Vafai JJ, Washenik K. Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 1998;39(5Pt1):751-61
-
(1998)
J Am Acad Dermatol
, vol.39
, Issue.5
, pp. 751-761
-
-
Rokhsar, C.K.1
Shupack, J.L.2
Vafai, J.J.3
Washenik, K.4
-
64
-
-
0026082648
-
Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone
-
Van der Steen PH, van Baar HM, Happle R, et al. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991;24(2Pt1):227-30
-
(1991)
J Am Acad Dermatol
, vol.24
, Issue.2
, pp. 227-230
-
-
Van Der Steen, P.H.1
Van Baar, H.M.2
Happle, R.3
-
65
-
-
0025742887
-
Alopecia areata in children: Response to treatment with diphencyprone
-
MacDonald Hull S, Pepall L, Cunliffe WJ. Alopecia areata in children: response to treatment with diphencyprone. Br J Dermatol 1991;125(2):164-8
-
(1991)
Br J Dermatol
, vol.125
, Issue.2
, pp. 164-168
-
-
MacDonald Hull, S.1
Pepall, L.2
Cunliffe, W.J.3
-
66
-
-
0029743894
-
Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis
-
Tosti A, Guidetti MS, Bardazzi F, Misciali C. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. J Am Acad Dermatol 1996;35(2Pt1):199-201
-
(1996)
J Am Acad Dermatol
, vol.35
, Issue.2
, pp. 199-201
-
-
Tosti, A.1
Guidetti, M.S.2
Bardazzi, F.3
Misciali, C.4
-
67
-
-
0037388494
-
Lentiginous eruption due to topical immunotherapy
-
Tosti A, Piraccini BM, Misciali C, Vincenzi C. Lentiginous eruption due to topical immunotherapy. Arch Dermatol 2003;139(4):544-5
-
(2003)
Arch Dermatol
, vol.139
, Issue.4
, pp. 544-545
-
-
Tosti, A.1
Piraccini, B.M.2
Misciali, C.3
Vincenzi, C.4
-
68
-
-
0029620668
-
PUVA treatment of alopecia areata partialis, totalis and universalis: Audit of 10 years' experience at st john's institute of dermatology
-
Taylor CR, Hawk JL. PUVA treatment of alopecia areata partialis, totalis and universalis: Audit of 10 years' experience at St John's Institute of Dermatology. Br J Dermatol 1995;133(60):914-18
-
(1995)
Br J Dermatol
, vol.133
, Issue.60
, pp. 914-918
-
-
Taylor, C.R.1
Hawk, J.L.2
-
69
-
-
0027184062
-
PUVA treatment for alopecia areata-does it work? A retrospective review of 102 cases
-
Healy E, Rogers S. PUVA treatment for alopecia areata-does it work? A retrospective review of 102 cases. Br J Dermatol 1993;129(1):42-4
-
(1993)
Br J Dermatol
, vol.129
, Issue.1
, pp. 42-44
-
-
Healy, E.1
Rogers, S.2
-
70
-
-
84907227637
-
Excimer laser: A module of the alopecia areata common protocol
-
McMichael AJ. Excimer laser: A module of the alopecia areata common protocol. J Invest Dermatol Symp Proc 2013;16(1):S77-9
-
(2013)
J Invest Dermatol Symp Proc
, vol.16
, Issue.1
, pp. S77-S79
-
-
McMichael, A.J.1
-
71
-
-
70350023131
-
308-nm excimer laser for the treatment of alopecia areata in children
-
Al Mutairi N. 308-nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol 2009;26(5):547-50
-
(2009)
Pediatr Dermatol
, vol.26
, Issue.5
, pp. 547-550
-
-
Al Mutairi, N.1
-
72
-
-
84922496418
-
Treatment of alopecia areata with simvastatin/ezetimibe
-
Lattouf C, Jimenez JJ, Tosti A, et al. Treatment of alopecia areata with simvastatin/ezetimibe. J Am Acad Dermatol 2015;72(2):359-61
-
(2015)
J Am Acad Dermatol
, vol.72
, Issue.2
, pp. 359-361
-
-
Lattouf, C.1
Jimenez, J.J.2
Tosti, A.3
-
73
-
-
84908315856
-
Alopecia areata is driven by cytotoxic lymphocytes and is reversed by JAK inhibition
-
Xing L, Dai Z, Jabbari A, et al. Alopecia areata is driven by cytotoxic lymphocytes and is reversed by JAK inhibition. Nat Med 2014;20(9):1043-9
-
(2014)
Nat Med
, vol.20
, Issue.9
, pp. 1043-1049
-
-
Xing, L.1
Dai, Z.2
Jabbari, A.3
-
74
-
-
84904130542
-
Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata
-
Castela E, Le Duff F, Butori C, et al. Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata. JAMA Dermatol 2014;150(7):748-51
-
(2014)
JAMA Dermatol
, vol.150
, Issue.7
, pp. 748-751
-
-
Castela, E.1
Le Duff, F.2
Butori, C.3
-
75
-
-
84883420789
-
A randomized, double-blind, placeboand active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata
-
Trink A, Sorbellini E, Bezzola P, et al. A randomized, double-blind, placeboand active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata. Br J Dermatol 2013;169(3):690-4
-
(2013)
Br J Dermatol
, vol.169
, Issue.3
, pp. 690-694
-
-
Trink, A.1
Sorbellini, E.2
Bezzola, P.3
-
76
-
-
45749158921
-
Management of primary cicatricial alopecias: Options for treatment
-
Harries Mj, Sinclair RD, MacDonald-Hull S, et al. Management of primary cicatricial alopecias: options for treatment. Br J Dermatol 2008;159(1):1-22
-
(2008)
Br J Dermatol
, vol.159
, Issue.1
, pp. 1-22
-
-
Harries, M.J.1
Sinclair, R.D.2
MacDonald-Hull, S.3
-
77
-
-
84908887283
-
Red face revisited: Disorders of hair growth and the pilosebaceous unit
-
Ramos-e-Silva M, Pirmez R. Red face revisited: Disorders of hair growth and the pilosebaceous unit. Clin Dermatol 2014;32:784-99
-
(2014)
Clin Dermatol
, vol.32
, pp. 784-799
-
-
Ramos-e-Silva, M.1
Pirmez, R.2
-
78
-
-
84895812536
-
Lichen planopilaris: Epidemiology and prevalence of subtypes-a retrospective analysis in 104 patients
-
Meinhard J, Stroux A, Lünnemann L, et al. Lichen planopilaris: Epidemiology and prevalence of subtypes-a retrospective analysis in 104 patients. J Dtsch Dermatol Ges 2014;12(3):229-35
-
(2014)
J Dtsch Dermatol Ges
, vol.12
, Issue.3
, pp. 229-235
-
-
Meinhard, J.1
Stroux, A.2
Lünnemann, L.3
-
79
-
-
0347003662
-
Primary cicatricial alopecias: Clinicopathology of 112 cases
-
Tan E, Martinka M, Ball N, Shapiro J. Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol 2004;50(1):25-32
-
(2004)
J Am Acad Dermatol
, vol.50
, Issue.1
, pp. 25-32
-
-
Tan, E.1
Martinka, M.2
Ball, N.3
Shapiro, J.4
-
80
-
-
47549112316
-
Lichen Planopilaris
-
Kang H, Alzolibani AA, Otberg N, Shapiro J. Lichen Planopilaris. Dermatol Ther 2008;21(4):249-56
-
(2008)
Dermatol Ther
, vol.21
, Issue.4
, pp. 249-256
-
-
Kang, H.1
Alzolibani, A.A.2
Otberg, N.3
Shapiro, J.4
-
81
-
-
63049089516
-
Lichen planopilaris: Update on diagnosis and treatment
-
Assouly P, Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg 2009;28(1):3-10
-
(2009)
Semin Cutan Med Surg
, vol.28
, Issue.1
, pp. 3-10
-
-
Assouly, P.1
Reygagne, P.2
-
82
-
-
84922575303
-
The use of oral pioglitazone in the treatment of lichen planopilaris
-
Mesinkovska NA, Tellez A, Dawes D, et al. The use of oral pioglitazone in the treatment of lichen planopilaris. J Am Acad Dermatol 2015;72(2):355-6
-
(2015)
J Am Acad Dermatol
, vol.72
, Issue.2
, pp. 355-356
-
-
Mesinkovska, N.A.1
Tellez, A.2
Dawes, D.3
-
83
-
-
0033373872
-
Low molecular weight heparin: A novel alternative therapeutic approach for lichen planus
-
Stefanidou MP, Ioannidou DJ, Panayiotides JG, Tosca AD. Low molecular weight heparin: A novel alternative therapeutic approach for lichen planus. Br J Dermatol 1999;141:1040-5
-
(1999)
Br J Dermatol
, vol.141
, pp. 1040-1045
-
-
Stefanidou, M.P.1
Ioannidou, D.J.2
Panayiotides, J.G.3
Tosca, A.D.4
-
84
-
-
81855168388
-
Low-dose excimer 308-nm laser for treatment of lichen planopilaris
-
Navarini A, Kolios AG, Prinz-Vavricka BM, et al. Low-dose excimer 308-nm laser for treatment of lichen planopilaris. Arch Dermatol 2011;147(11):1325-6
-
(2011)
Arch Dermatol
, vol.147
, Issue.11
, pp. 1325-1326
-
-
Navarini, A.1
Kolios, A.G.2
Prinz-Vavricka, B.M.3
-
85
-
-
11144313119
-
Frontal fibrosing alopecia in postmenopausal women
-
Tosti A, Iorizzo M, Piraccini BM, Misciali C. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol 2005;52(1):55-60
-
(2005)
J Am Acad Dermatol
, vol.52
, Issue.1
, pp. 55-60
-
-
Tosti, A.1
Iorizzo, M.2
Piraccini, B.M.3
Misciali, C.4
-
87
-
-
33644873943
-
Female pattern hair loss and its relationship to permanent/cicatricial alopecia: A new perspective
-
Olsen EA. Female pattern hair loss and its relationship to permanent/cicatricial alopecia: A new perspective. J Investig Dermatol Symp Proc 2005;10(3):217-21
-
(2005)
J Investig Dermatol Symp Proc
, vol.10
, Issue.3
, pp. 217-221
-
-
Olsen, E.A.1
-
89
-
-
47649093456
-
Folliculitis decalvans
-
Otberg N, Kang H, Alzolibani AA, Shapiro J. Folliculitis decalvans. Dermatol Ther 2008;21(4):238-44
-
(2008)
Dermatol Ther
, vol.21
, Issue.4
, pp. 238-244
-
-
Otberg, N.1
Kang, H.2
Alzolibani, A.A.3
Shapiro, J.4
-
91
-
-
80052969201
-
Innate immunity: A crucial target for zinc in the treatment of inflammatory dermatosis
-
Brocard A, Dreno B. Innate immunity: A crucial target for zinc in the treatment of inflammatory dermatosis. J Eur Acad Dermatol Venereol 2011;25(10):1146-52
-
(2011)
J Eur Acad Dermatol Venereol
, vol.25
, Issue.10
, pp. 1146-1152
-
-
Brocard, A.1
Dreno, B.2
-
92
-
-
84890396155
-
Long-term remission of folliculitis decalvans after treatment with the long-pulsed Nd:YAG laser
-
Meesters AA, Van der Veen JP, Wolkerstorfer A. Long-term remission of folliculitis decalvans after treatment with the long-pulsed Nd:YAG laser. J Dermatol Treat 2014;25(2):167-8
-
(2014)
J Dermatol Treat
, vol.25
, Issue.2
, pp. 167-168
-
-
Meesters, A.A.1
Van Der Veen, J.P.2
Wolkerstorfer, A.3
-
93
-
-
84901189715
-
Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): A comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa
-
Scheinfeld N. Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): A comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa. Dermatol Online J 2014;20(5):22692
-
(2014)
Dermatol Online J
, vol.20
, Issue.5
, pp. 22692
-
-
Scheinfeld, N.1
-
94
-
-
84922282428
-
Dissecting cellulitis of the scalp: A retrospective study of 7 cases confirming the efficacy of oral isotretinoin
-
Koudoukpo C, Abdennader S, Cavelier-Balloy B, et al. Dissecting cellulitis of the scalp: A retrospective study of 7 cases confirming the efficacy of oral isotretinoin. Ann Dermatol Venereol 2014;14(8-9):500-6
-
(2014)
Ann Dermatol Venereol
, vol.14
, Issue.8-9
, pp. 500-506
-
-
Koudoukpo, C.1
Abdennader, S.2
Cavelier-Balloy, B.3
-
95
-
-
84861366665
-
Treatment options for alopecia: An update, looking to the future
-
Miteva M, Tosti A. Treatment options for alopecia: An update, looking to the future. Expert Opin Pharmacother 2012;13(9):1271-81
-
(2012)
Expert Opin Pharmacother
, vol.13
, Issue.9
, pp. 1271-1281
-
-
Miteva, M.1
Tosti, A.2
-
97
-
-
84863344412
-
Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia
-
Garza LA, Liu Y, Yang Z, et al. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci Transl Med 2012;4(126):126ra34
-
(2012)
Sci Transl Med
, vol.4
, Issue.126
, pp. 126-134
-
-
Garza, L.A.1
Liu, Y.2
Yang, Z.3
|